• Seres Therapeutics (NASDAQ:MCRB) Price Target Cut to $0.75 by Analysts at The Goldman Sachs Group

    Source: Buzz FX / 15 Mar 2025 14:45:17   America/New_York


    Seres Therapeutics (NASDAQ:MCRB) Price Target Cut to $0.75 by Analysts at The Goldman Sachs Group Written by MarketBeat March 15, 2025 Share Link copied to clipboard. Remove Ads Seres Therapeutics ( NASDAQ:MCRB - Get Free Report ) had its t
    Read more...
Share on,